Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 18
Healthy volunteers: yes

Brief summary:
To investigate the relative bioavailability of BI 10773 following coadministration with 600 mg gemfibrozil bid dosed to steady-state in comparison to BI 10773 when given alone.

Detailed description:

Arms:
arm 1: Subject to receive one single dose BI 10773 arm 2: Subject to receive one single dose BI 10773 plus 600 mg gemfibrozil bid for 5 days

Interventions: intervention 1: BI 10773 intervention 2: Gemfibrozil intervention 3: BI 10773
Intervention descriptions: intervention 1: 1 tablet single dose BI 10773 in the morning intervention 2: Gemfibrozil 600 mg bid for 5 days intervention 3: 1 tablet single dose BI 10773 in the morning

Protocol document: